New Immulina(R) Could Boost Resistance To The H1N1 Virus

Main Category: Swine Flu
Also Included In: Flu / Cold / SARS;  Public Health
Article Date: 08 Sep 2009 - 5:00 PDT

email to a friend   printer friendly   view / write opinions

Now that the World Health Organisation (WHO) has officially declared a global flu pandemic, the need to protect ourselves and our families from infection has become critical. In the UK, there has already been well over 7,000 cases of a new strain of swine-origin Influenza A virus subtype H1N1 diagnosed and it is now reaching all areas of the country. Schools in particular have felt the impact, with Eton College a good example of how pupils have had to be quarantined from outside contact until the infected individuals have recovered fully. In addition, Sandhurst military academy and Top Shop on Oxford Street have each confirmed cases, which could lead to the further spread of the virus.

Launching in the UK is a new product which supports your body's natural defences. Immulina®, is 'the most powerful natural immuno-stimulatory product ever discovered.'

Immulina® is a brand new, unique, scientifically tested and scientifically proven natural food supplement which the whole population may benefit by taking every day to support the body's immune system by maintaining the function of the immune system cells. It is a patented and proprietary extract based on a bioactive micro algae complex from Arthrospira Platensis and its unique formulation means it is 20-25 times more bioactive than many other products². It also differs from antibiotics or anti-viral drugs by acting as a resistance booster.

A New Scientific Study shows Immulina® has a substantial effect on ameliorating symptoms caused by the virus H1N1. The recently concluded animal study reported by Scandinavian Clinical Nutrition (SCN) in May 2009, was conducted at the Louisiana State University School of Veterinary Medicine, Division of Biotechnology & Molecular Medicine (BIOMED). "The results are promising with regard to preventative effects and milder symptoms of H1N1 infection. Immulina® tested in mice, showed a significant reduction of both symptoms and lung tissue damage after being infected by the influenza virus H1N1, compared to placebo," says Dr. Lars Lindmark, CEO of Kasima Medical Development AB, who has been involved with the research of Immulina® during the last five years.

It should be noted that this trial did not test against the new swine-origin strain of H1N1 influenza A specifically, but demonstrated the potential for Immulina® to help manage the impact of H1N1 in general.

The study leader, Professor Gus Kousoulas summarised the outcome of the research: "The experimental results collectively indicate a substantial effect of the nutritional supplement on ameliorating clinical symptoms and adverse pathological implication of influenza infection in the mouse model and lead us to believe that this micro algae compound may be able to boost resistance to H1N1 influenza".

Further studies on the immune-enhancing effects of Immulina® on humans and animals have been conducted at several renowned immunology specialist organisations, such as the Karolinska Institutet in Stockholm and at Rigshospitalet in Copenhagen, resulting in several published articles in peer-reviewed scientific journals.

Arriving in the UK from this week, Immulina® offers genuine support in enabling families to boost the body's natural immune system. Available from Nutri Centre www.nutricentre.com / call 08456026744, pharmacies and health food stores, Immulina® costs £24.95 for around one month's supply of 30 capsules, to be taken once daily.

Notes

Immulina® - Product Profile
Patented bioactive Arthrospira platensis complex
- Supports the body's natural resistance
- Maintains the function of immune system cells
Dosage: 1 capsule a day. If feeling stressed or tired, you may take 2 capsules a day. Daily dosage should not be exceeded.

1 capsule contains:
200mg patented Arthrospira platensis extract (59%), corresponding to 1.5g dried algae arthrospira platensis.
Pregnant women and children under 12 months should consult with a health care professional before taking the product.
Made in the UK.

Source
WHO